The effectiveness of photobiomodulation in the management of temporomandibular pain sensitivity in rats: behavioral and neurochemical effects

Lasers Med Sci. 2020 Mar;35(2):447-453. doi: 10.1007/s10103-019-02842-0. Epub 2019 Jul 10.

Abstract

This study analyzed the effects of photobiomodulation (PBM) with low-level laser therapy on nociceptive behavior and neuronal activity in the trigeminal nucleus after experimental unilateral temporomandibular joint (TMJ) disc injury. The animals were divided into 4 groups (n = 10 each): group 1, surgical injury of the articular disc and PBM; group 2, sham-operated subjected to PBM; group 3, surgical injury of the articular disc; and group 4, control (Naïve). Ten sessions of PBM were performed using GaAs laser with a wavelength of 904 nm, power of 75 W pico, average power of 0.043 W, area of the beam of 0.13 cm2, duration of the pulses of 60 nseg (in the frequency of 9500 Hz), energy density of 5.95 J/cm2, energy per point of 0.7 J, and power density of 333.8 mW/cm2, and the irradiation was done for 18 s per point. Neuropathic symptoms were evaluated using the von Frey test. Trigeminal ganglion samples underwent immunoblotting to examine the expression of substance P, vanilloid transient potential receptor of subtype-1 (TRPV-1), and peptide related to the calcitonin gene (CGRP). There was a total decrease in pain sensitivity after the second session of PBM in operated animals, and this decrease remains until the last session. There was a significant decrease in the expression of SP, TRPV-1, and CGRP after PBM. Photobiomodulation therapy was effective in reducing nociceptive behavior and trigeminal nucleus neuronal activity after TMJ disc injury.

Keywords: Low-level laser therapy; Nociception; Temporomandibular joint; Temporomandibular joint disc; Trigeminal nuclei.

MeSH terms

  • Animals
  • Behavior, Animal
  • Calcitonin Gene-Related Peptide / metabolism
  • Lasers, Semiconductor
  • Low-Level Light Therapy*
  • Male
  • Neuropeptides / metabolism*
  • Pain / radiotherapy*
  • Pain Threshold*
  • Rats, Wistar
  • Substance P / metabolism
  • TRPV Cation Channels / metabolism
  • Temporomandibular Joint / pathology*
  • Temporomandibular Joint / radiation effects*
  • Treatment Outcome

Substances

  • Neuropeptides
  • TRPV Cation Channels
  • Trpv1 protein, rat
  • Substance P
  • Calcitonin Gene-Related Peptide

Grants and funding